Treatment with this selective inhibitor inhibits inflammation and preserves the regenerative effects of IL-6 in mouse models of a wide variety of diseases, e.g., ulcerative colitis, rheumatoid arthritis, and acute pancreatitis-associated lung injury (56). Here, IL6 is linked to rheumatoid arthritis.